What is CRON (CRON) stock price today?

CRON (CRON) is currently trading at $2.83, down 2.08% today.

What is CRON P/E ratio?

CRON's P/E ratio is -131.00. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is CRON return on equity (ROE)?

CRON's return on equity (ROE) is 0.45%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is CRON's market cap?

CRON has a market capitalization of $1.06B.

NASDAQ · Drug Manufacturers - Specialty & Generic

CRON (CRON) Stock

$2.83 -2.08% NASDAQ: CRON Healthcare

Valuation

Metric	Value
Price	$2.83
Market Cap	$1.06B
P/E Ratio	-131.00
P/B Ratio	0.92
P/S Ratio	6.18
EPS (TTM)	$0.00
52-Week High	$3.43
52-Week Low	$1.84
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	0.45%
ROA	-0.78%
ROCE	-0.26%
Gross Margin	42.19%
Operating Margin	-7.77%
Net Margin	-1.29%
Debt/Equity	0.00
Current Ratio	19.67

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$65.0M	$87.0M	$87.0M	$118.0M	$193.0M
Operating Profit	$-292.0M	$-111.0M	$-85.0M	$-77.0M	$-3.0M
Net Profit	$-396.0M	$-169.0M	$-74.0M	$41.0M	$-9.0M
EPS	$-1.07	$-0.45	$-0.19	$0.11	$-0.02
Op Margin	-452.2%	-128.4%	-97.2%	-65.1%	-1.5%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$1.4B	$1.2B	$1.1B	$1.2B	$1.2B
Total Liabilities	$63.0M	$72.0M	$44.0M	$55.0M	$54.0M
Cash	$887.0M	$765.0M	$669.0M	$859.0M	$792.0M
Borrowings	$10.0M	$4.0M	$3.0M	$2.0M	$2.0M

Latest News

Cronos Group Inc. to Hold 2026 Second Quarter Earnings Conference Call on August 6, 2026 GlobeNewswire · Jul 16, 2026 TLRY Plans Strategic Medical Cannabis Expansion: Time to Buy or Sell? Zacks · Jul 2, 2026 Cronos Announces Appointment of ATB Cormark as its Broker for Share Repurchases in Canada GlobeNewswire · Jun 30, 2026 CRON Strengthens Global Footprint: Is the Cannabis Stock Worth Buying? Zacks · Jun 24, 2026 Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders GlobeNewswire · Jun 22, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-154.0M	$-89.0M	$-43.0M	$19.0M	$26.0M
Investing Cash Flow	$-41.0M	$-7.0M	$-63.0M	$162.0M	$-110.0M
Financing Cash Flow	$-13.0M	$-3.0M	$-1.0M	$-1.0M	$-20.0M
Net Cash Flow	$-191.0M	$-122.0M	$-95.0M	$190.0M	$-68.0M
Free Cash Flow	$-166.0M	$-94.0M	$-46.0M	$6.0M	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	-115510.63
FCF Yield	2.69%
Quick Ratio	20.73
Interest Coverage	—
Return 1Y	31.10%
Return 3Y	48.11%
Return 5Y	-63.53%

Ownership

Insiders Held48.55%

Institutions Held15.64%

Institutions Float Held30.39%

Institutional Holder	Shares	Report Date
Chescapmanager LLC	7,942,737	2026-03-31
Shaw D.E. & Co., Inc.	7,618,227	2026-03-31
Pillsbury Lake Capital LLC	4,223,004	2026-03-31
Tidal Investments LLC	4,026,892	2026-03-31
Dimensional Fund Advisors LP	2,679,051	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AMPH	$20.22	+1.40%	12.02	$891.56M	0.00%
BBOT	$8.09	-4.82%	-3.62	$648.07M	0.00%
COLL	$35.58	+0.54%	17.33	$1.15B	0.00%
EMBCEmbecta Corp.	$3.46	+5.17%	1.72	$205.27M	1.22%
IRMD	$95.08	+0.62%	46.31	$1.22B	1.43%

About CRON

CRON is led by CEO Michael Ryan Gorenstein, employs 459 people, headquartered in CA, publicly traded since 2018.

CRON stock trades at $2.83 with a market capitalization of $1.06B. The stock is valued at a price-to-earnings (P/E) ratio of -131.00, price-to-book of 0.92, price-to-sales of 6.18. Over the past 52 weeks the stock has ranged between $1.84 and $3.43, and currently trades 17.5% below its 52-week high.

On profitability, CRON generates a return on equity (ROE) of 0.45%, return on capital employed of -0.26%, an operating margin of -7.77%, a net profit margin of -1.29%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides